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In evaluating paricnts we have noted disparity between the 
locations of bound itnmunoreactants and the level of blister-
ing in epidermolysis bullosa acquisita (EBA). We examined 
10 consecutive EDA patients by routine histology, direct 
(DIF) and indirect (llF; intact and NaCl-split skin) immuno-
fluorescence, immunofluorescence mapping (1M), and/or 
direct immunoelectron microscopy (DIEM). DIF was posi-
tive in each. IlF was positive in 3/8 and 6/7 patients when 
intact and split skin were used as substrates. DIEM revealed 
immunoreactants within the lamina densa (LD) in 6/10, 
sub-LD in 1/10, and both LD and sub-LD in 3/10 patients. 
In contrast, by DIEM and 1M, blister formation was noted 
within the lamina lucida (LL) in 7/9 and 8/10, sub-LD in 
1/9 and 1/ 10, and within both LL and sub-LD in 1/9 and 
I n recent years, several autoimmune dermatoses, including bullous pemphigoid, cicatricial pemphigoid, dermatitis her-pctiformis (OH), linear IgA dermatosis, lupus erythemato-sus, and epidermolysis buJlosa acquisita (EBA) have been more ~recisely characterized by a variety of immunologic 
techniques [IJ. As a result. it is now apparent that many paticms 
previously classified on the basis of clinical and direct inullunofluo-
rescence findings as having bullous pemphigoid instead have EBA 
[2J. 
It is generally acceptcd that the ultrastrucrural site of tissue-bound 
immunoreactants in most autoimmune discases of the skin corre-
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1/10, respectively. In the presence of neutrophils within the 
uppet dermis (n = 6), cleavage occurred within the LL in 5 
specimens; in one additional specimen containing predomi-
nantly neutrophils, cleavage occllrred within both LL and 
sub-LD. In the presence of mononuclear cells (n = 2), intra-
LL cleavage occurred. In the presence of eosinophils, cleav-
age occutred within both LL and sub-LD. In the one speci-
men lacking any infiltrate, the cleavage plane was exclusively 
sub-LD. Intra-LL cleavage planes are morc common than 
sub-LD ones in at least early cases of ERA. These findings 
likely represent the intra-LL-separaring effecr of leukocyte-
derived proteolytic enzymes, when such cells are chemoat-
rracted to the dermoepidermal junction by bound immuno-
reactants. J Illvest Dermatol 92:27 -32, 1989 
lates with the level of blister formation (i.e .• both reaction products 
and cleft formation within the lamina lucida) [IJ.ln the case ofDH, 
however, tissue-bound immunoreactants have been localized to the 
sub-lamina densa region of the basement membrane zone [3 -5J, 
whereas, more reccndy, skin cleavage has been shown to occur 
within the lamina lucida itsclf[6.7]. This disparity has been ascribed 
to an inherelU weakness ("locus resistensia minoris") of the lamina 
lucida {6J. In the course of studies of patients with several of thesc 
autoimmune diseases. we have noted a similar disparity in skin spec-
imens from patients with proven EDA. We now report on our 
findings in ten consecutive patients with EBA and propose an alter-
mae explanation for the findings most commonly seen in both OH 
and EBA. 
MATERIALS AND METHODS 
Patients Examined 10 patients (4 maJe, 6 female). with an aver-
age age of 62 (range, 41-82) , subsequently shown to have EBA, 
were included. A summary of thcirclinical findings is listed in Table 
1. The diagnosis of EBA was considered in those bullous disease 
patients meeting the following minimal criteria: positive direct im-
munofluorcscence for linear homogeneous immunoreactant(s) 
(other than only IgA) along (he dermocpidermal junction, demon-
stration of tissue-bound immunoreactants within and/or below the 
lamina densa (by direct immunoelectron microscopy), and lack of 
clinical and serologic findings suggestive of systemic lupus ery-
themarosus [8 -1 0]. When possible, indirect immunofluorescence 
on intact and NaCI-split skin was also performed; when the latter 
study was positive. the diagnosis of ERA was furthcr confirmed by 
the detcction of anti-basement mcmbrane autoantibody staining 
solely upon the dermal base of sllch intra-lamina lucida separated 
skin [II J. 
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Table I. Summary of Clinical Findings of 10 Patients with EBA 
-------------------
Patient Age' Sex Symptoms Duration!> I)rurirus Burning 
1 59 M 
2 69 F 
3 56 F 
4 62 F 
5 81 M 
6 47 M 
7 64 F 
8 82 F 
9 41 F 
10 54 M 
(Uttic.:uial) 
Extent of lesions 
81110. 
1 d,y 
3 mo. 
3 mo. 
4 mo. 
18 mo. 
6 yr. 
6 mo. 
6 yr. 
3 yr. 
Leslonal Morphology 
Erosions Milia 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
8 
+ 
+ 
+ 
+ 
+ 
+ 
6 
VesiclesJbullae plaques 
---------------------- ---~~--------------------~~--------~~-
Scarring Mechanical Fragility 
Genef2lized 
Gencralizcd & mouth 
Ext", mouth , & conjunctiva 
Generalized & mouth 
Upper body &. month 
Gcncnlized 
Extremities 
Gcnenlized 
Generalized 
Generalized, momh. and Gld tract 
• At lime of d'''gnosis. 
h Pnor to defimtive dlagnom . 
• Ext; extremities. 
01 GI: g:utrointesunal. 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
10 
+ 
+ 
2 
Routine Histology 4-mm punch biopsies were obtained from 
lesional skin in 10 patients. Each specimen was stained with hema-
{Qxylin and eosin and examined for both the level of skin cleavage 
(intraepidermal versus subepidermal) and the type(s) of inflamma-
tory cell(s) present within the blister cavity and within the dermal 
perivascular infiltrate. 
Direct Immunofluorescence (DIF) Studies OfF was per-
formed on perilesional skin (n = 10). lesional skin (n = 1), and 
normal-appearing buccal mucosa (n = 1) by a standard technique 
urilizing FlTC-conjugated goat antihuman antibodies to IgG. IgA. 
IgM, IgE, and fibrinogen (Cappel Laboratories, Cochranville, PAl. 
Indirect Immuno flu orescence (IIF) Studies JlF was per-
formed on both intact normal human skin (n ~ 8) (both adult skin 
and neonatal foreskin) and NaCI-split human skin (n = 7). the lat-
tcr as previously reported 1111. In brief, the latter tissue substrate was 
prepared by first subjecting intact human skin to 1.0 M NaCI solu-
tIOn for 72 h at 4 · C, following which the epidermis was carefully 
removed mechanically from the underlying dermis, and both speci-
mens snap frozen in O.C.T. embedding medium (Lab-Tek Prod-
ucts, Napersville, J L), and stored at -70°C until needed. Eight-mi-
cron-thick cryostat sections were prepared from each frozen 
specimen and a two-step if F procedure was performed on each of 
the two human skin substrate preparations utilizing undiluted and 
serially dilured serum from each EDA patient (in two-fold dilutions 
through 1: 32, in 0.0067 M phosphate buffered saline (pH 7.4). 
Following incubation at room temperature in a humidified chamber 
for 30 min, each specimen was briefly rinsed in PBS, further incu-
bated for 30 min in the presence of FITC-cOl~ugated goat anti-
human IgG (1: 40 dilution; Cappel Laborarories). further rinsed in 
PBS, and then examined by epi-illumination with a Leitz Laborlux 
J 2 immunofluorescence microscope. following rhe mounting of 
each tissue-containing slide with 50% glycerol in PBS. Controls for 
+ + + + 
+ + 
+ + 
+ + + 
+ + + + 
+ + 
+ + + + 
+ 
+ + + + 
+ + + + 
9 6 7 8 
the split skin studies included previously documented bullous pem-
phigoid antisera (positive controls) and normal human sera (nega-
tive controls). 
Immuno8uorescence Mapping (1M) Studies Immunofluores-
cence mapping [12.13J was performed on 11 specimens previously 
examined by DIF technique, These specialized indirectimmunoflu-
orescence studies were performed utilizing well-characterized po-
Iyclonal antibodies to the following skin basement membrane anti-
gens: bullous pemphigoid antigen, laminin. and type IV collagen, 
As controls. we utilized normal sera from the appropriately matched 
species (human. sheep). These mapping studies were performed as 
previously described over a range of anribody titers (anti-bullous 
pemphigoid antigen, I : 10- 1 :20; anti-Iaminin. and anti-type IV 
collagen, 1: 40 - 1: 1280) known to result in strong positive stain-
ing on normal intact and NaCI-separated human skin and on skin 
specimens from patients with each of the three forms of inherited 
epidermolysis bullosa. FITC-conjugated goat anti-human IgG 
(1: 40) and rabbit anti-sheep IgG (1: 20) (Cappel Laboratories) were 
employed as second step immunoreagents. Incubation times and 
temperatures were identical to those used for split-skin studies. De-
termination of the site(s) of in vivo bound immunoreactants was 
accomplished by cxamining such tissues following incubation with 
normal human serum (1: 10-1 : 20), Subsequently. the localization 
of each of the three above-mentioned antigens. and therefore the 
level of skin cleavage in each specimen, was detennined by compar-
ing the staining of basement membrane with each of thesc poly-
clonal antibodies and with normal human serum. Specifically, 
intra-lamina lucida cleavage was characterized by the presence of 
bullous pemphigoid antigen on the roof and laminin and type IV 
collagen along the base of the blister. whereas in sub-lamina dcnsa 
cleavage all three antigens were noted along the blister roof. consist-
em with the ultrastructural localization of each of these antigens in 
normal intact human skin. 
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Direct Immunoclectron Microscopic (IEM) Studies Direct 
IEM was performed on 11 specimens prcviously examined by DIF 
technique, using methodology previously described 114,15 J. In 
brief, 10-J~m-thick cryostat sections of unfixed human skin or mu-
cosa were prepared, and serial incubations (room temperature, 30 
min) were carried out with the following sequence of immunorea-
gems: normal rabbi t serum (to block nonspecific binding of later 
steps). goat antihuman immunoglobulin or C3 (the specific OIlC 
chosen dependent on the OIF findings in each specimen), rabbit 
antigoat IgG. goat peroxidase-anti-peroxidase. and a Tris buffer 
solution (pH 7.6) containing diaminobenzidine and hydrogen per-
oxide. Following extensive washing in PBS, each specimen was 
then further prepared for evaluation by transmission electron mi-
croscopy as previously described (! 4, 15J. 
RESULTS 
Clinical findings on the 10 patients included in this study are sum-
marized in Table I. In seven patients. the eruption was generalized; 
mucosal involvement was noted in five. The most common din..ical 
findings included vesicle o r bulla formation (10/10). erosions 
(9/ I 0), mechanical fr:tgiliry (8/10), and scar formarion (7/ I 0). Less 
frequently, milia and urticarial plaques were also observed. Most 
patients were symptOmatic for either pruritus (8/10) or a marked 
burning sensation of the skin (6/10). 
Direct and indirect immunofluorescence findings and those of 
routine histology are depicted in Table II. Twelve tissue specimens 
were obtai ned from these patients. In all but two specimens. the 
biopsies were from perilesional skin. The most common tissue-
bound immunoreactants were IgG and C3, each of which was noted 
in 9/10 patients (11/12 specimens). Less frequently. fibrinogen. 
IgA. IgM. and in one patient, IgE. were also detected. When com-
pared to specimens frolll patients with bullous pemphigoid, in 
which only twO immulloreactants, IgG and C3, are usually detect-
able along the dermoepidermaljunction [1], 7/10 EBA patients had 
at least three in vivo bound immunoreactants presem along the 
dermoepidermal junction. 
Similar to that previously reported in EBA {2,1Ol. slighdy less 
than 40% of our subjects had detectable anti-basement membrane 
autoantibodies when intact human skin was used as the tissue sub-
strnte. In contrast, 6/7 of the sera examined had detectable anti-
basement membrane au toantibodies when NaCI-split human skin 
was utilized as substrate. Identica l to that previously published in 
EBA [III, rhese autoantihodies bound solely to rhe dermal portion 
of the intra-lamina lucida separated skin. In contrast, control anti-
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Table 1lI. Direct Immunoelectron Microscopic (IEM) and 
Immunofluorescence Mapping (1M) Findings 
IEM 
Patient Oound-IRb 
I LD' 
2 LD 
3 LD' 
4 LD. sub-LD 
5 LD 
6 LD. sub-LO 
7 Suh-LD 
8 LD. sub-LO 
9 LD 
10 LD 
• On e;ach of 2 )pccimclIs. 
• IR: IIIlIllUllorc;act;ants. 
e LL: bmma luclda. 
~ LO: lallllna densa. 
• (-): nOf Ylsu.alizcd. 
1M 
Cleft(s) Bound-IRIt 
LL' Basc 
LL B"" 
LL Base & roof-
LL, sub-LD Base 
LL B"" 
LL Base 
Sub-LD Roof 
LL Base 
LL Base 
(-)' B"e 
C left (s) 
LL 
LL 
LL' 
LL 
LL 
LL 
Sub-LD 
LL. sub-LD 
LL 
LL 
sera frolll several patients with bullous pemphigoid bound exclu-
sively to the undersurface of the separated epidermal roof (data not 
shown). 
As noted in Table II, some inflammatory infiltrate was noted in 
all but one specimen. The most common type of inflammatory ce ll 
detected was the polymorphonuclear leukocyte (6/10). Less com-
monly. mononuclear cells (2/ 10) or eosinophils (1/10) predomi-
nated. 
Direct IEM and 1M were performed in 11 specimens from these 
10 EBA patients; results are depicted in Table III. In 9/1 1 speci-
mens, a single cleavage plane was detectable. In two specimens. a 
second and more minor cleavage plane was also focally present. 
With the few exceptions noted in Table III, there was consistency 
in the findings observed by both direct l EM and 1M techniques. In 
10/1 t specimens. tissue-bound immunoreactants were noted by 1M 
exclusively on one side of the blister (9 dermal base, 1 epidermal 
rool). corresponding to those findings noted by direct lEM (Fig 
lA - D). In one specimen, both epidermal roof and dermal base 
cOlltained tissue-bound immune deposits. By direct IEM. all illl-
munoreactan(S were shown to reside within the lamina dcnsa. sub-
lamina dellsa, or both lamina densa and sub-lamina densa regions in 
7, I, and 3 specimens, respectively. consistent with previously pub-
Table II. Romine Histologic and Direct and Indirect Immunofluorescence Findings in EBA 
--------
DIP liP (on skin) 
Pt Site' Cdlul~r Inflltr:ue IgG IgA IgM IgE C3 Fibrinogell Intact Split 
------'=----
LcsiQn~1 PMN' + + + + + 
Periiesional PMN + + + + 
2 Perilesional PMN + + + + + 
3 Periiesiollal Monoe + + + + + + 
Nonnal bucc.1 mUCQs. Mono + + + 
4 Pcnlesioll.1 PMN + + + 
5 Perilcsion.l PMN + + + 
6 Pcrilesionai MOllo + + + + 
7 Pcrilesio!l.l None + + 
8 Perilesional Eos' + + + + 
9 Pcrilesional PMN + + + + 
10 Perilesional PMN + + + + + 
n - positive p:arienrs 9 5 4 9 6 3/ 8 6/7 
(total z:t; 10 unless noted) 
• Skin exeepl where noted. 
~ DIF: dlrw unmunolluoresccncc. 
< lIF: indlrcct immunofluorc.\Ccllcc. 
d PMN: polymorphonuclear Icukocytcs. 
r MOllo: mononuclcar leukocytes. 
I Eos: eosmophiJs. 
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Figure 1. IrmnunoAuorescence mapping srudyon ~rilesion:.1 EBAskin, using antibodies to bullous ~mphigoid antigen (A) ,l:.minin (B). type IV collagen 
(C), and normal human serum (D). The distribution of antibody binding in A-C is indicative of intr2-lamina lucidl. cleavage, whereas staining in D 
demonsrrates the localization of in vivo bound immunore:llct2nu to be within or bene:llth the level of the lamina densa. (A : SSOx; B: 13ax; C and D: 344x). 
lished data on skin from patients with £SA [2,8-11]' as depicted in 
Figs 2 and 3. Similar localization of tissue-bound immunoreactants 
was deduced from 1M findings. 
The location of cleavage plane(s) detectable by 1M and direct lEM 
was compared CO the predominant type of inflammatory cell within 
the infiltrate. Although none of the EDA tissue specimens contained 
tissue-bound immunoreactants within the lamina lucida, exclusive 
intra-lamina lucida cleavage was noted in 7/10 specimens (Fig 1-
3). J n five of these sevcn patients, the primary dermal inflammatory 
cell was the polymorphonuclear leukocyte; in two, mononuclcar 
cells were noted. In two addidonal patients, a second and smaller 
cleft was noted in the sub-lamina densa region; in these patients, 
polymorphonuclear leukocytes or eosinophils were nOled. In con-
trast, in the one patient having exclusively sub-lamina densa blister 
formation. no inflammamty cellular infiltrate was noted. 
DISCUSSION 
Several aumimmune skin diseases, includ.ing bullous pemphigoid, 
cicatricial pemphigoid, and herpes gestationis, have both blister 
formation and tissue-bound immunoreactants within the lamina 
lucida [1,16,17J. In contrast, in two autoimmune bullous diseases. 
epidermolysis bullosa acquisita [2,8-11] and bullous eruption of 
systemic lupus erythematosus (18-20), tissue-bound immunoreac-
tants have been shown to reside with the lamina densa and/or sub-
lamina densa regions. In addition, it has been reported that blister 
formation in both conditions occurs beneath the region of the lam-
ina den" [8.9.18-20]' 
Based upon our experience with 10 consecutive paricnrs subse-
quently shown to have ERA by direct LEM and NaCI-split skin 
studies. the presence of three or more tissue-bound immunoreac-
tants along the dermoepidermal junction in a linear homogeneous 
pattern appears to be an early clue to the diagnosis of EBA; simi.lar 
direct immunofluorescence findings have been previously noted by 
others in EllA [21] and also have been reported recently in cicatricial 
pemphigoid [151. As previously reported. antiskin basement mem-
brane autoantibodies were secn in the majority of our EBA patients 
when NaCI-split skin was used as the tissue substrate for I1 F, 
whereas such autoantibodies were detectable in only about 40% of 
patients when intact human skin was employed. The high fre-
quency of antiskin basement membrane autoantibodies detectable in 
EllA and their exclusive binding to the dermal portion of NaCI-
split skin further confirms the usefulness of this latter substrate in 
both diagnosing EDA and readily differentiating this entity from 
bullous pemphigoid. 
In contrast to previous reportS. however. a majority of specimens 
from our series of EllA patients were noted to have intra-lamina 
lucida skin cleavage rather than sub-lamina densa clefts. Infre-
quently, both intra-lamina lucida and sub-lamina dCllsa clefts or 
exclusively sub-lamina densa clefts were noted. These findings may 
be comrasted to the presence of lamina dcnsa and/or sub-lamina 
densa-bound immunoreactants in all patients that we have exam-
ined with EBA. 
When the localization of skin cleavage was compared to the 
findings seen on routine histology, there appears to be a correlation 
between the presence of leukocytes within the upper dermis directly 
underneath the dcrmo-epidcnnal junction and [he presence of 
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Figure 2. Direct immunoclectron microscopy of peri-
lesional skin from paticnt 2, dcmonstrating tissue-bound 
immunoreactants within and beneath the lamina densa 
(solid arrowheads) and earl y blister rormation within the 
lamina lucida (so lid arrow). (magnification: 2S,OOOx). 
intra- lamina lucida cleavage. That is. a predominant or exclusive 
imra- ialllina lucida cleavage plane was noted in each of the nine 
EllA patients having leukocytic infihrates within the upper dermis 
adjacent to the dermo-epidermal junction. These latter findings 
may be analogous to those reporred in dermatiti s herpetiformis. in 
which a neutrophilic infiltrate is present within the upper papillary 
dermis, ti ssue-bound immunoreaC[ants are loca lized to the sub-lam-
ina densa re~ ion . and blister formation may occur within the lamina 
lucida 13 -7 J. In contrast, only sub-lamina densa cleavage was detec-
table in the one paticJ1{ lacking an inflammatory de rmal infiltrate, 
further suggesting the poss ibility of a causative ro le for leukocytes 
in the development of intra-lamina lucida separatio n in ERA. De-
spite this latter observation, however, it is clear that furth er critica l 
evaluatio n of a large series of specimens from EllA patients lacking 
apparent dermal inflammatio n will be neccssary to substantiatc tit e 
validi ty o f this hypothesis. 
Recent experiments have demo nstrated that normal human leu-
kocytes, particularly po lymorphonuclear leukocytes, are capable o f 
releasing enzymes which. when incubated in vitro with sections o f 
intact human skin, lead to intra-lamina lucida separation and subse-
q.uent dissolution o f the basement mcmbrane zone [22]. These latte r 
findings suggest a model which appears to explain the apparen t 
dispari ty between thc level of blister formation and that of tissue-
bound immunoreactants in both dermatitis herpetiform is and EBA. 
It is possible that cleavage in DH occurs within the lamina lucida 
because of the activity of proteolytic e.nzymes that havc been re-
leased by leukocytes chcllloa ttracted to the defino-epidermal junc-
tion by tissue-bound IgA in that vicinity; in this manner, enzymatic 
d egradatio n of o ne or more components within lhe lami na lucida 
would lead to eventual cleft formatio n at that location. Similarly, it 
is likely, at least in earl y cases o f EBA, that the presence of tissue-
bound immunorcactants within the lamina densa and/or sub-lam-
ina densa may result in the chemoattraction to the dermo-epidermal 
j unctio n of one or mo re types of leukocytes which subsequently 
release enzymes leading to intra- lamina lucida blister formation 
f231. Bt"c:l.tIse some patients with EBA and neutrophilic inflamma-
tory infilrrates do have sub-lamina densa c1cavage. however, it is 
obvious that othcr factors, possibly including the duration of dis-
ease, the level or extent of disease activity, and/or additional me-
chanical instability of the derma-epidermal junction due to alter-
ations in anchoring fibril s. microfibrill ar bundles, collagen, and/or 
elastic fibers 124J, and the quantity and extent of tissue-bound illl-
munoreactants within the sub-lamina densa region in some patients 
Illay also contribute to deeper levels of skin cleavage and blister 
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formatio n than that observed in our present series of patients. For 
example. one reasonable explanation fo r the disparity in findin gs 
be tween our patient population and those previously described is 
the rather shorr duration o f di sease in the former group. As a result 
of our prospecti vel y evaluating all newly diagnosed paticnts with 
autoi mmune bullous deflnatoses by direct LEM during the course o f 
this study, we were able to study most EBA patients during the 
earliest course (frequently refe rred to as the inflammatory stage) of 
their disease; in six of the nine with inflammatory infiltrates, the 
average o nset of d isease was o nly 6 months prior to our evaluation. 
As previously noted , the skin biopsy from onc of our paticnts (no. 7) 
lacked any evidence of inflammatory infiltrate; this same patient 
was the o nly one noted to have exclusively sub-lamina densa bli ster 
form3tion. Although it is unknown wh y such deep cleavage oc-
curred in th is patient , a few possible ex planations can be suggested. 
Fi rst. the du ratio n of disease activity in th is patient was at least 6 
years. As such, the chronicity of disease in this particular patient 
may have allowed for ex tensive damage to the upper dermal struc-
tures, incl uding anchoring fibrils. thereby predisposing the skin to 
sub-lamina densa cleavage. Second, longstand ing depositio n of im-
ll1unoreactants within the sub-lamina densa may have furth er com-
promised the mechanica l in tegrity of th is region. Third, in the 
absence of leukocytes and their enzymatic products. there was no 
additio nal complica ting tissue inj ury favoring intra -lamina lucida 
rather than sub-lamina densa blister fo rmation. 
As a practical point, the diagnosis o f EDA cannot be excluded 0 11 
the basis of the demonstration of intra-lamina lucida cleavage by 
either routine transmission elec tron microscopy or immunofluores-
ccnce mapp ing tech niq ues unlc~s cOllcurren t Jirect IEM de mo n-
strates that these immunoreaccants are present within (i.e., as in 
bullous pemphigoid) rather than benea th the lamina lucida. Fur-
thermore, th is may explain the fi ndings in one recent study of 
bullous pemphigoid in w hich some patients. in part defined as hav-
ing bullous pemphigoid by the presence of intra- lamina lucida 
cleavage. were noted to have immunoreaction products benea th 
that ultrastructural region 1251; presumably those patients in fact 
had EllA with cl inical fea tures mimicking those of bullous pemphi-
goid [2]. Considering the frequent cl inical similarity between bul -
lous pemphigoid and EllA, the defin itive differentiatio n o f these 
two enrities should rest upon rhe fi ndings of at least one of twO 
specialized techniques: direct IEM or, if available and positive, the 
results of immunoblot analysis of circulating autoantibodies when 
the latte r are exposed to ex tracted bullous pemphigoid and EBA 
antigens. 
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Figure 3. Higher magnification of Fig 2. Opt'l arrows identify lamina dells2 
and sub-lamina densa tissue-bound immunoreact2nU and arrowheads demon-
strate marked focal separation within the level of the lamina lucida. (magni-
fication: 82.500x). 
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